Comparison between effectiveness of two different molecular weights of hyaluronic acid on shoulder tendinopathy.

Phase 3

Conditions: Rotator cuff tendinopathy.
Unsp rotatr-cuff tear/ruptr of left shoulder, not trauma.
M75.102

Registration Number: IRCT20170608034390N5

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 56

Inclusion Criteria

Tendinopathy of Rotator Cuff
?Adults (16-70 years)
At least 6 weeks from the onset of pain

Exclusion Criteria

Pregnant or lactating Women
Active systemic rheumatologic disorders
Coagulopathies or on anticoagulant medication
Diabetes mellitus
Active septic disorders or history of cancers or tumors around the site of shoulder joint
Use of systemic corticosteroid drugs recently in one month

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity based on visual analogue scale. Timepoint: Measuring the severity of pain at the beginning of the study (before the intervention), one week, one month and three months after the injection. Method of measurement: Visual Analogue Scale (VAS).

Secondary Outcome Measures

Name	Time	Method
Range of Motion (ROM). Timepoint: Measuring the range of motion at the beginning of the study (before the intervention), one week, one month and three months after the injection. Method of measurement: Goniometer.;Adverse events (e.g., Inflammation in the injection site). Timepoint: Inflammation in the injection site at the first week of study after the injection. Method of measurement: Hyperemia, warmth, pain, tendonitis, tenderness.;The disabilities of the arm, shoulder and hand. Timepoint: Measuring the disabilities of the arm, shoulder and hand at the beginning of the study (before the intervention), one week, one month and three months after the injection. Method of measurement: The Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire.;Quality of life. Timepoint: Measuring the Quality of life at the beginning of the study (before the intervention), one week, one month and three months after the injection. Method of measurement: QOL-BREF Questionnaire.